Artificial intelligence-based decision support for axial spondyloarthritis integrating inflammatory and structural MRI information
6 affiliations
- 1Medical Artificial Intelligence (AI) Research Center, Research Institute for Future Medicine, Samsung Medical Center
- 2Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology (SAIHST), Sungkyunkwan University
- 3Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine
- 4Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine
- 5Department of Data Convergence and Future Medicine, Sungkyunkwan University School of Medicine
- 6Department of Biomedical Software Engineering, The Catholic University of Korea
Abstract
Background: Axial spondyloarthritis (axSpA) assessment on MRI is complicated by interpretation difficulty and by clinical variables that may be incomplete at the time of imaging. We aimed to develop an image-only deep learning framework to approximate the clinical assessment of axSpA from sacroiliac joint (SIJ) MRI, integrating fat-suppressed T1-weighted (FS T1) and short tau inversion recovery (STIR) sequences to capture structural and inflammatory information without clinical variables.
Methods: This retrospective study included patients with chronic back pain who underwent SIJ MRI from January 2010 to December 2021. The treating rheumatologist’s clinical diagnosis served as the reference standard. A two-stage framework integrated FS T1 and STIR features with Stage 1-derived binary bone marrow edema (BME) predictions to generate an axSpA probability. Performance in a test set was compared with the Assessment of SpondyloArthritis International Society (ASAS) definition of a “positive MRI” and the ASAS classification criteria using exact McNemar tests; discordant cases were analyzed separately.
Results: Among 291 patients (163 axSpA, 128 non-axSpA), the model achieved an AUROC of 0.9412, accuracy of 86.0%, sensitivity of 87.5%, and specificity of 84.0% in the test set (n=57). No significant paired differences in accuracy, sensitivity, or specificity were detected between the model and either ASAS comparator. In an exploratory analysis of 10 cases discordant between ASAS “positive MRI” assessment and clinical diagnosis, the model correctly classified 7 (70.0%).
Conclusion: The model showed similar performance to the ASAS-based comparators in the test set without clinical variables, suggesting potential value as an image-based decision-support tool. External multicenter validation is needed to confirm generalizability.
Related
- Converging Paths: Artificial Intelligence for Integrating Biological and Digital Biomarkers in Personalized Longevity Medicine
- Artificial Intelligence for Predictive Microbiome Engineering: Integrating Community Design and Environmental Validation
- Adaptive Precision Nutrition: Integrating Dynamic Phenotyping, Multi-Omics, Artificial Intelligence, and the Allostatic Viability Principle
- Neutrophils in spondyloarthritis pathogenesis: from inflammatory infiltration to bone remodeling
- Strategies for integrating artificial intelligence and cognitive assessment to predict disability progression in relapsing-remitting multiple sclerosis: A model development study
BibTeX
@article{kim2026artificial,
title = {{Artificial intelligence-based decision support for axial spondyloarthritis integrating inflammatory and structural MRI information}},
author = {Yunseo Kim and Seulkee Lee and Seonyoung Kang and Jaejoon Lee and Myung Jin Chung and Ji Hyun Lee and Hakje Yoo and Hoon-Suk Cha},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1950510},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1950510/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Artificial intelligence-based decision support for axial spondyloarthritis integrating inflammatory and structural MRI information
AU - Yunseo Kim
AU - Seulkee Lee
AU - Seonyoung Kang
AU - Jaejoon Lee
AU - Myung Jin Chung
AU - Ji Hyun Lee
AU - Hakje Yoo
AU - Hoon-Suk Cha
PY - 2026
DA - 2026/10/19
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1950510
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1950510/full
AB - Background: Axial spondyloarthritis (axSpA) assessment on MRI is complicated by interpretation difficulty and by clinical variables that may be incomplete at the time of imaging. We aimed to develop an image-only deep learning framework to approximate the clinical assessment of axSpA from sacroiliac joint (SIJ) MRI, integrating fat-suppressed T1-weighted (FS T1) and short tau inversion recovery (STIR) sequences to capture structural and inflammatory information without clinical variables. Methods: This retrospective study included patients with chronic back pain who underwent SIJ MRI from January 2010 to December 2021. The treating rheumatologist’s clinical diagnosis served as the reference standard. A two-stage framework integrated FS T1 and STIR features with Stage 1-derived binary bone marrow edema (BME) predictions to generate an axSpA probability. Performance in a test set was compared with the Assessment of SpondyloArthritis International Society (ASAS) definition of a “positive MRI” and the ASAS classification criteria using exact McNemar tests; discordant cases were analyzed separately. Results: Among 291 patients (163 axSpA, 128 non-axSpA), the model achieved an AUROC of 0.9412, accuracy of 86.0%, sensitivity of 87.5%, and specificity of 84.0% in the test set (n=57). No significant paired differences in accuracy, sensitivity, or specificity were detected between the model and either ASAS comparator. In an exploratory analysis of 10 cases discordant between ASAS “positive MRI” assessment and clinical diagnosis, the model correctly classified 7 (70.0%). Conclusion: The model showed similar performance to the ASAS-based comparators in the test set without clinical variables, suggesting potential value as an image-based decision-support tool. External multicenter validation is needed to confirm generalizability.
SN - 1664-3224
ER -